ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc (REGN)

633,29
-0,85
( -0,13% )
Aktualisiert: 18:21:13
Fortg. Diagramm

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
633,29
Gebot
633,43
Fragen
634,08
Volumen
302.789
629,02 Tagesbereich 644,00
629,02 52-Wochen-Bereich 1.211,1999
Marktkapitalisierung
Handelsende
634,14
Handelsbeginn
634,14
Letzte Trade
1
@
633.6576
Letzter Handelszeitpunkt
18:21:35
Finanzvolumen
US$ 192.804.245
VWAP
636,7611
Durchschnittliches Volumen (3 Mio.)
926.951
Ausgegebene Aktien
109.324.682
Dividendenrendite
0.56%
Kurs-Gewinn-Verhältnis
15,71
Gewinn pro Aktie (EPS)
40,36
Erlöse
14,2B
Nettogewinn
4,41B

Über Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL ... Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Health Care Diversified
Hauptsitz
New York, New York, USA
Gegründet
1988
Regeneron Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker REGN. The last closing price for Regeneron Pharmaceuticals was US$634,14. Over the last year, Regeneron Pharmaceuticals shares have traded in a share price range of US$ 629,02 to US$ 1.211,1999.

Regeneron Pharmaceuticals currently has 109.324.682 shares in issue. The market capitalisation of Regeneron Pharmaceuticals is US$69,33 billion. Regeneron Pharmaceuticals has a price to earnings ratio (PE ratio) of 15.71.

Option-Flow Regeneron Pharmaceuticals (REGN)

Gesamtfluss

Bullisch

Nettoprämie

5M

Calls / Puts

134,62%

Käuf. / Verkä.

79,41%

OTM / ITM

103,33%

Sweeps

0,00%

REGN Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-30.38-4.57757620504663.67674.83629.02981592657.21574495CS
4-88.115-12.2143594791721.405748.29629.02952006686.07365105CS
12-91.12-12.5785121685724.41748.29629.02926951691.70823216CS
26-425.01-40.1596900691058.31070629.02855714765.79500889CS
52-328.7-34.168754353961.991211.1999629.02657556865.10606979CS
156-43-6.35821910719676.291211.1999538.01622999790.79802047CS
260206.7848.4818644346426.511211.1999424.02735752678.68086265CS

REGN - Frequently Asked Questions (FAQ)

What is the current Regeneron Pharmaceuticals share price?
The current share price of Regeneron Pharmaceuticals is US$ 633,29
How many Regeneron Pharmaceuticals shares are in issue?
Regeneron Pharmaceuticals has 109.324.682 shares in issue
What is the market cap of Regeneron Pharmaceuticals?
The market capitalisation of Regeneron Pharmaceuticals is USD 69,33B
What is the 1 year trading range for Regeneron Pharmaceuticals share price?
Regeneron Pharmaceuticals has traded in the range of US$ 629,02 to US$ 1.211,1999 during the past year
What is the PE ratio of Regeneron Pharmaceuticals?
The price to earnings ratio of Regeneron Pharmaceuticals is 15,71
What is the cash to sales ratio of Regeneron Pharmaceuticals?
The cash to sales ratio of Regeneron Pharmaceuticals is 4,88
What is the reporting currency for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Regeneron Pharmaceuticals?
The latest annual turnover of Regeneron Pharmaceuticals is USD 14,2B
What is the latest annual profit for Regeneron Pharmaceuticals?
The latest annual profit of Regeneron Pharmaceuticals is USD 4,41B
What is the registered address of Regeneron Pharmaceuticals?
The registered address for Regeneron Pharmaceuticals is 28 LIBERTY STREET, NEW YORK, NEW YORK, 10005
What is the Regeneron Pharmaceuticals website address?
The website address for Regeneron Pharmaceuticals is www.regeneron.com
Which industry sector does Regeneron Pharmaceuticals operate in?
Regeneron Pharmaceuticals operates in the HEALTH CARE DIVERSIFIED sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PTPIPetros Pharmaceuticals Inc
US$ 0,1765
(205,36%)
1,36B
OCEAOcean Biomedical Inc
US$ 0,12295
(116,46%)
514,7M
OSRHOSR Holdings Inc
US$ 3,239
(102,44%)
74,5M
VVPRVivoPower International PLC
US$ 4,00
(76,99%)
128,91M
SURGSurgePays Inc
US$ 2,20
(59,42%)
63,19M
BACKIMAC Holdings Inc
US$ 0,071
(-64,50%)
1,14M
ACRVAcrivon Therapeutics Inc
US$ 3,35
(-37,85%)
913,54k
TNONTenon Medical Inc
US$ 2,53
(-32,53%)
16,41M
HUMAHumacyte Inc
US$ 2,025
(-29,57%)
16,94M
BHILBenson Hill Inc
US$ 0,30
(-29,15%)
702,41k
PTPIPetros Pharmaceuticals Inc
US$ 0,1765
(205,36%)
1,36B
OCEAOcean Biomedical Inc
US$ 0,12295
(116,46%)
514,7M
LYTLytus Technologies Holdings PTV Ltd
US$ 0,072
(42,29%)
196,1M
NVDANVIDIA Corporation
US$ 113,835
(-5,68%)
182,06M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,4712
(-11,64%)
158,04M

REGN Finanzen

Finanzen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock